Navigation Links
Abaxis To Report Fourth Quarter And Fiscal Year 2013 Financial Results Thursday, April 25, 2013
Date:4/17/2013

UNION CITY, Calif., April 17, 2013 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, has scheduled a conference call to discuss its financial results for the fourth quarter and fiscal year 2013, ended March 31, 2013. The call will be at 4:15 p.m. ET on Thursday, April 25, 2013.  The Company will report financial results for the fourth quarter and fiscal year 2013 after the market closes on Thursday, April 25, 2013.

Participants can dial (877) 317-6789 or (412) 317-6789 to access the conference call, or can listen via a live Internet web cast, which is available in the Investor Relations section of the Company's website at www.abaxis.com. A replay of the call is available by visiting www.abaxis.com for the next 30 days or by calling (877) 344-7529 or (412) 317-0088, confirmation code 10027780, through May 1, 2013.

About AbaxisAbaxis develops, manufactures, markets and sells portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements.  The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients.  The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples.  The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer.  The veterinary business also provides to the animal health and research market a line of hematology instruments for point-of-care complete blood counts (CBC), a specialty instrument to screen for and detect clotting disorders and to measure equine fibrinogen levels, a handheld instrument for the rapid assessment of certain critical care tests and rapid point-of-care tests for Heartworm infections, Parvovirus, Giardia and Lyme disease.  Abaxis, through its AVRL division, provides routine laboratory testing as well as specialty testing for veterinarians nationwide.Contact:

Clint SeversonLytham Partners, LLC Chief Executive Officer 

Joe Dorame, Joe Diaz & Robert Blum Abaxis, Inc.602-889-9700 510-675-6500
'/>"/>

SOURCE Abaxis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Abaxis, Inc. to Present at the Sidoti & Company Seventeenth Annual Institutional Investor Forum
2. Abaxis, Inc. to Present at the Raymond James 34th Annual Institutional Investor Conference
3. Abaxis to Present at Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference
4. Abaxis Reports Record Revenues For The Third Quarter Of Fiscal 2013
5. Abaxis To Report Third Quarter Fiscal Year 2013 Financial Results Thursday, January 31, 2013
6. Abaxis Declares Special Cash Dividend of $1.00 Per Share
7. Abaxis, Inc. to Present at 24th Annual Piper Jaffray Healthcare Conference
8. Abaxis, Inc. to Participate in Sidoti & Companys Inaugural One-on-One Conference
9. Abaxis, Inc. to Present at the Stephens Fall Investment Conference
10. Abaxis, Inc. to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
11. Abaxis Announces Exclusive Distribution Agreement with Abbott
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on ... Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ability ... fumigation is not a common occurrence, but a necessary one in the event that lice ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... To deal with these feelings, many turn to unhealthy avenues, such as drug or ... Center of Marne, Michigan, has released tools for healthy coping following a traumatic event. ...
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are ... Code Talker Award, an essay contest in which patients and their families pay tribute ... presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) ...
Breaking Medicine News(10 mins):